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Review question
The aim of the systematic review is to critically appraise, synthesise and present the available evidence of
patients’ lived experiences of cytotoxic medications prescribed for the management of malignant solid
tumours. 
In relation to the patients’ pharmacological treatment journey for the management of malignant solid
tumours:• What are the patients’ lived experience?• What is the medication related burden? • What are the
medication related beliefs?• What is the medication taking practice?• What is the relationship between the
lived experience and medication related burden, medication related beliefs and medication taking practice?
 
Searches
Systematic review according to PRISMA guidelines will be conducted in the following databases: CINAHL,
MEDLINE, Cochrane Library, Science Direct, Springerlink, International pharmaceutical abstracts and
PsycArticles. 
Manual searches of related studies listed in the reference, footnote and citations will be carried out to include
more relevant papers. The search will be restricted to publications in the English language and will centre on
the concepts of patients’ lived experience, cytotoxic medications and malignant solid tumours. Concept
mapping was applied to develop keywords and generate search terms.
 
Types of study to be included
All study designs of research studies which have employed any methodological approach including
quantitative or mixed methodologies will be included.
 
Condition or domain being studied
The lived experiences of adult patients prescribed cytotoxic medications for the management of malignant
solid tumours.
 
Participants/population
Inclusion criteria: patients who are 18 years and over irrespective of their gender, ethnicity and stage of
disease receiving cytotoxic medications for the management of malignant solid tumours.
 
Intervention(s), exposure(s)
Articles will be reviewed if they describe the patients’ lived experience of cytotoxic medications for the
management of malignant solid tumours.
 
Comparator(s)/control
Not applicable.
 
Context
 
Primary outcome(s)
The primary outcomes will include the experiences, burden, beliefs and practice of patients in relation to
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cytotoxic medications.
 
Secondary outcome(s)
None.
 
Data extraction (selection and coding)
The initial screening of all titles retrieved during the search will be carried out to identify potentially relevant
papers. This will be followed by screening of abstracts and then by full paper against the pre-defined
systematic review aim, questions and inclusion/exclusion criteria. A random sample of 10% of the retrieved
titles and abstracts during the search strategy will be independently checked by two research members for
consistency of inclusion/exclusion and enhance the reliability of the process. Any disagreement will be
resolved by consensus within the research team; otherwise these will be reported in the final review. Any
duplicate publications of the same studies will be eliminated and the number of duplicates will be recorded
using Prisma 2009 flow diagram.
Qualitative and quantitative data extraction will be conducted using standardised data extraction tools. These
will be developed so as to obtain specific information pertinent to the review aim and questions.
 
Risk of bias (quality) assessment
Quality assessment will be conducted on all included manuscripts by two independent reviewers using
established critical appraisal tools. Disagreements will be resolved by consensus after discussion with the
research team.
 
Strategy for data synthesis
Depending on the uncertainty of data that will be retrieved, it is difficult to anticipate strategies for data
synthesis. However the synthesis would most likely be narrative. Key findings and conclusion will be
generated in relation to the review aim and questions.
 
Analysis of subgroups or subsets
None planned
 
Contact details for further information
Ms Brincat
a.brincat@rgu.ac.uk
 
Organisational affiliation of the review
Robert Gordon University, Aberdeen Scotland
 
Review team members and their organisational affiliations
Ms Alison Brincat. School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen Scotland
Dr Lorna Marie West. School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen Scotland
and Department of Clinical Pharmacology and Therapeutics, University of Malta, Msida Malta
Professor Derek Stewart. School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen
Scotland
Dr Anita Weidmann. School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen Scotland
 
Anticipated or actual start date
01 October 2016
 
Anticipated completion date
28 February 2017
 
Funding sources/sponsors
The project will be funded by the ‘Get Qualified Scheme’ upon successful completion of the doctorate
course.
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Conflicts of interest
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Language
English
 
Country
Scotland
 
Stage of review
Review_Ongoing
 
Subject index terms status
Subject indexing assigned by CRD
 
Subject index terms
Antineoplastic Agents; Disease Management; Humans; Neoplasms
 
Date of registration in PROSPERO
27 September 2016
 
Date of publication of this version
27 September 2016
 
Details of any existing review of the same topic by the same authors
 
Stage of review at time of this submission
The review has not started
 
Stage Started Completed
Preliminary searches No No
Piloting of the study selection process No No
Formal screening of search results against eligibility criteria No No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
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